IL17A and depressive symptom measurement: The interaction between depressive symptoms and IL-17 in predicting MMSE scores persisted in post hoc models controlling for hypertension, dyslipidemia, history of depression, antidepressant use, NSAID use, lesion location, NIHSS scores, and time between phlebotomy and assay.